Výsledky vyhledávání - "Vivian H, Shih"

Akademický článek

Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison

Autor: Azeem Majeed, Liam G Heaney, Zhiyi Lan, Tamsin Morris, Olivia Fulton, Adrian P J Rabe, Wei J Loke, Danuta Kielar, Vivian H Shih, Lynda Olinger, Mihaela G Musat, Sharada Harricharan

Publikováno v: BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)

Introduction Effective treatment of severe asthma requires patient adherence to inhaled and biological medications. Previous work has shown that patient support programmes (PSP) can improve adherence in patients with chronic diseases, but the impact

Externí odkaz: https://doaj.org/article/51f2b637096243fca634b9a2028a55b5

Zobrazit plný text záznamu

Akademický článek

Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary—Child (PAD-C) and Pediatric Asthma Diary—Observer (PAD-O)

Autor: Helena Bradley, Claire Trennery, Amy M. Jones, Aoife Lydon, Frances White, Rebecca Williams-Hall, Rob Arbuckle, Erin Tomaszewski, Vivian H. Shih, John Haughney, Amanda Eisen, Tonya Winders, Stephen Joel Coons, Sonya Eremenco, the Patient-Reported Outcome Consortium’s Pediatric Asthma Working Group

Publikováno v: Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-16 (2023)

Abstract Background Pediatric asthma has been identified by regulators, clinicians, clinical trial sponsors, and caregivers as an area in need of novel fit-for-purpose clinical outcome assessments (COAs) developed in accordance with the U.S. Food and

Externí odkaz: https://doaj.org/article/a06b4cc6786e4c27bb658d71af0d8d5d

Zobrazit plný text záznamu

Akademický článek

The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach

Autor: Eduardo Genofre, Donna Carstens, Wilfried DeBacker, Patrick Muchmore, Reynold A. Panettieri, Kirsty Rhodes, Vivian H. Shih, Frank Trudo

Publikováno v: Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)

Abstract Background Severe eosinophilic asthma (SEA) is characterised by elevated blood/sputum eosinophil counts and airway inflammation, which can lead to mucus plug-mediated airway obstruction, increased exacerbation frequency, declines in lung fun

Externí odkaz: https://doaj.org/article/efd6e565154e493e8f91c9408dc475ae

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

The Bronchiectasis Exacerbation Diary: a novel patient-reported outcome for non-cystic fibrosis bronchiectasis

Autor: Vivian H. Shih, Maria Jison, Erik Bark, Meredith Venerus, Oren Meyers, James D. Chalmers

Publikováno v: ERJ Open Research, Vol 9, Iss 3 (2023)

Bronchiectasis is a chronic, progressive lung disease believed to result from a vicious cycle of infection and inflammation, with symptoms of chronic cough with sputum production, chronic fatigue, rhinosinusitis, chest pain, breathlessness and haemop

Externí odkaz: https://doaj.org/article/4241805c230d429ca942e43b99955b8e

Zobrazit plný text záznamu

Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary

Autor: Sean O'Quinn, Vivian H. Shih, Ubaldo J. Martin, Oren Meyers, Patrick Crooks, Julie Bailey, Ashley F. Slagle

Publikováno v: International Forum of Allergy & Rhinology. 12:996-1005

This qualitative study assessed the experience of patients with chronic rhinosinusitis with nasal polyposis (NP) to inform the development of a novel symptom diary for clinical study use.Concept elicitation and cognitive interviews were conducted wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb21b78e0f48f56e249ed65766793f9
https://doi.org/10.1002/alr.22952

Zobrazit plný text záznamu

Plný text ve formátu HTML

Identifying super-responders to benralizumab in severe asthma

Autor: Annie Burden, David A. Jackson, Francesco Menzella, Esther Garcia Gil, Tim Harrison, Vivian H. Shih

Publikováno v: Airway pharmacology and treatment.

Introduction: Severe eosinophilic asthma is increasingly recognised as a heterogeneous phenotype. Benralizumab has a unique ability to deplete blood and tissue eosinophils. Assessing clinical characteristics of patients who have a marked response to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1534936aa0114f032f393fb75fc43eab
https://doi.org/10.1183/13993003.congress-2021.pa3734

Zobrazit plný text záznamu

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Autor: James Kreindler, Maria Jison, Martin Desrosiers, Claire Emson, Viktoria Werkström, David Cohen, Claire Hopkins, Ubaldo J. Martin, Vivian H. Shih, Joseph K. Han, Sofia Necander, Philippe Gevaert, Peter Barker, Claus Bachert, Enrico Heffler, Jody R. Tversky

Publikováno v: The Journal of allergy and clinical immunology. 149(4)

Background Eosinophilic inflammation has been implicated in the pathogenesis, severity, and treatment responsiveness of chronic rhinosinusitis with nasal polyps (CRSwNP). Objective We sought to assess the efficacy and safety of benralizumab-mediated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a6474b070f7fcea0e78df4c5fa34fe
https://pubmed.ncbi.nlm.nih.gov/34599979

Zobrazit plný text záznamu

Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial

Autor: Richard F. Olsson, Raburn M. Mallory, Vivian H. Shih, Pamela L. Zeitlin, Jeremy Cole, Mitchell Goldman, Mila Leong

Publikováno v: Journal of Asthma and Allergy

Pamela L Zeitlin,1 Mila Leong,2 Jeremy Cole,3 Raburn M Mallory,4 Vivian H Shih,5 Richard F Olsson,6 Mitchell Goldman5 On behalf of the ALIZE study investigators 1Department of Pediatrics, National Jewish Health, Denver, CO, USA; 2Pediatric Pulmonary

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f86b59d3a0a11accde2b1994d2997c7
https://doi.org/10.2147/jaa.s172338

Zobrazit plný text záznamu

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies

Autor: Paul Newbold, Peter Barker, Alberto Papi, Maria Jison, Natalya Makulova, Laura Brooks, Dave Singh, Bartolome R. Celli, Alvar Agusti, Gerard J. Criner, Vivian H. Shih, Ubaldo J. Martin

Publikováno v: Criner, G J, Celli, B R, Singh, D, Agusti, A, Papi, A, Jison, M, Makulova, N, Shih, V H, Brooks, L, Barker, P, Martin, U J & Newbold, P 2019, ' Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(19)30338-8

SummaryBackgroundBenralizumab did not significantly reduce exacerbations compared with placebo in the phase 3 GALATHEA and TERRANOVA trials of benralizumab for patients with chronic obstructive pulmonary disease (COPD). We aimed to identify clinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a1a4d00d4ed42b7709076e1756b695
http://hdl.handle.net/11392/2414456

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání